RecruitingPhase 1NCT07361029

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
King Faisal Specialist Hospital & Research Center
Intervention
CAR T cells chimeric antigen receptor cells(other)
Enrollment
24 enrolled
Eligibility
18-75 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

Miltenyi Biomedicine GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07361029 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials